Access cutting-edge atopic dermatitis treatment through this clinical trial at a research site in Encinitas. Study-provided care at no cost to qualified participants.
Access atopic dermatitis specialists in Encinitas at no cost
This study follows strict safety protocols and ethical guidelines
All study-related atopic dermatitis treatment provided free
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema (atopic dermatitis), but these places may be very itchy. Participation in this study will last up to approximately 38 weeks (9 and a half months) including 24 weeks (6 months) of treatment.
Sponsor: Eli Lilly and Company
Check if you qualify for this atopic dermatitis clinical trial in Encinitas, CA
If you're searching for atopic dermatitis treatment options in Encinitas, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Encinitas research site is actively enrolling participants for this clinical trial. You'll receive care from experienced atopic dermatitis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.